ARTICLE | Company News
BioCryst, Idera drop merger plans
July 10, 2018 9:58 PM UTC
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) said it terminated its merger agreement with Idera Pharmaceuticals Inc. (NASDAQ:IDRA) after BioCryst stockholders failed to approve the merger in a special meeting held Tuesday...